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Defects in segregation lead to missing or lacking chromosomes (aneuploidy) in human eggs, 
a major cause of pregnancy failure and congenital disorders. Physical exchanges (crossovers) 
between homologous chromosomes are formed during foetal development and ensure that the 
pair remains tethered until their separation decades later in the meiotic divisions in adult 
oocytes. Here, we generate genome-wide maps of crossovers and chromosome segregation 
patterns by recovering all three products of single female meioses (embryo or oocytes and 
corresponding polar bodies). Genotyping > 4 million informative single-nucleotide 
polymorphisms (SNPs) from 23 complete meioses allowed us to map 2,032 maternal and 
1,342 paternal crossovers and to infer the segregation patterns from 529 chromosome pairs. 
We uncover a novel reverse chromosome segregation pattern in which both homologs 
separate their sister chromatids at meiosis I; detect selection for higher recombination rates in 
the female germline by the elimination of aneuploid embryos; and report chromosomal drive 
against non-recombinant chromatids at meiosis II. Collectively, our findings reveal that 
recombination not only affects homolog segregation at meiosis I but also the fate of sister 






Errors in chromosome segregation during the meiotic divisions in human female meiosis are 
a major cause of aneuploid conceptions, leading to implantation failure, pregnancy loss, and 
congenital disorders 
1
. The incidence of human trisomies increases exponentially in women 
from ~ 35 years of age, but despite conservative estimates that 10-30% of natural conceptions 
are aneuploid
2
, the underlying causes and their relative contributions are still unclear. In 
addition to maternal age, one important factor that is hypothesized to predispose to 
missegregation in both sexes is altered recombination. Recombinant chromosomes in the 
offspring are the result of crossovers, the reciprocal exchange of DNA between homologous 
chromosomes (homologs). Together with sister chromatid cohesion, crossovers physically 
link the homolog pair together during the prophase stage of meiosis (Fig. 1a), which takes 
place during foetal development in females. The linkages have to be maintained for decades, 
because the two rounds of chromosome segregation only occur in the adult woman. By 
following the pattern of genetic markers such as single nucleotide polymorphisms (SNPs) on 
the two chromosomes inherited from the mother in trisomic conceptions, it has been inferred 
that some crossovers occur too close to centromeres
1,3-6
, where they may disrupt the cohesion 
between the two sister chromatids
7,8
. Other crossovers have been suggested to be too far from 
the centromeres to mediate correct attachment, or to be lacking altogether (non-exchange, 
E0)
1,3-6
. If these inferences are correct, it follows that events that shape the recombination 
landscape in oocytes during foetal development of women affect their risk of having an 
aneuploid conception decades later in adult life.  
A limitation of these extensive population-based studies, however, is that only one of 
the products of meiosis is analysed (the oocyte). This prevents direct identification of the 
origin of chromosome segregation errors and provides only partial information on the 
crossovers during prophase of meiosis I. The missing data problem is so significant that 
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even the meiotic origin of age-related trisomies has been challenged recently
9
. Another 
confounding factor is that spontaneous miscarriages, still and live births on which our current 
knowledge is based represent only a minor fraction of the aneuploid embryos at conception. 
The majority of affected embryos are lost throughout pregnancy resulting in major preclinical 
and clinical losses
2
. Thus, to understand the origin of human aneuploidies, we need to assess 
all three meiotic products in unselected oocytes and embryos. 
 
Meiomapping of single meioses in oocytes and embryos. 
To follow genome-wide recombination and chromosome segregation simultaneously, we 
recovered all three products of female meiosis, which include the first and second polar 
bodies (PB1 and PB2) and the corresponding activated oocytes or fertilised embryos. We 
refer to these as oocyte-PB or embryo-PB trios (Fig 1a-c). 10 embryo-PB trios were obtained 
after normal fertilisation of the oocyte following intracytoplasmic sperm injection (ICSI). The 
embryos reached various stages of preimplantation  development and originated from a single 
donor having preimplantation genetic diagnosis for single gene defect and who consented to 
follow up genetic analysis of her embryos (Fig. 1a, Extended Data Table 1). A further 13 
trios were generated without fertilisation by activating mature MII-arrested oocytes with a 
calcium ionophore, which induced completion of MII and extrusion of the PB2 (Fig. 1b, 
Methods). This method was highly successful (85%, n=40, Extended Data Table 2) and did 
not alter the rate of meiosis II errors in the activated oocytes compared with embryos 
generated by ICSI (2%  versus 1.7%; Table 1). The oocyte-PB trios were obtained from five 
healthy female donors, who had cryopreserved unfertilised eggs in the course of fertility 
treatment but having achieved a pregnancy and live birth following IVF, consented to their 
remaining eggs being activated and undergoing genome analyses. The principle of isolating 
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all three meiotic products is similar to the approach of using the polar bodies and recovering 
the female pronucleus from zygotes
10
.  
The trio datasets were complemented with data on recombination and aneuploidy 
rates from 29 embryos (without polar bodies) in which SNP genotyping and karyomapping
11
 
had previously been used for preimplantation genetic diagnosis or screening. Because 
informative SNPs were available from both the mother and father, we were able to compare 
recombination in paternal and maternal chromosomes and their association with aneuploidy 
in embryos (Supplemental Table S1).  
All samples were amplified by whole genome amplification and genotyped at 
approximately 300,000 SNP loci genome-wide
11
. We detected  > 4 million informative SNPs 
at high stringency, which spanned > 92% of the genome, across the 23 complete trios 
(meioses), with an average resolution of 30 kb. For the oocyte-PB trios, genomic DNA from 
each donor was also genotyped to identify informative heterozygous SNP loci (hetSNPs). For 
the oocyte-PB trios, all heterozygous SNPs in the mothers genomic DNA are informative, 
whereas in embryos, maternal and paternal hetSNPs may be shared. Hence, the pattern of 
recombination in the paternal chromosomes was analysed by karyomapping (Handyside et al; 
Natesan et al) and only the two subsets of SNP loci which were heterozygous in the father 
and homozygous in the mother (or vice versa) were identified and used to phase the two 
haplotypes from the given parent in the embryo11,12. The informative SNPs were phased using 
siblings
10
 that contain only a single chromatid from their mother (PB2, oocytes or maternal 
chromatid in embryo) or father (embryos). The informative SNPs were phased by selecting a 
PB2 or oocyte/embryo as a reference (also known as assumed ancestor)
10
 and inferring the 
crossover positions in the assumed offsprings (i.e. trios from the same parent; Extended Data 
Fig. S1). Crossovers in the same position in the assumed offspring are highly unlikely to 
occur and these common crossovers can therefore be used to re-form the reference genome 
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from which the two haplotypes can be deduced (Extended Data Fig. S1). Since many of our 
samples were single cells, we validated our workflow on single cells by comparing 
recombination maps in 15 individual cells from a donor to the genomic DNA of the child, 
and by assessing 10 individual blastomeres from the same embryo for direct comparison. In 
all cases, concordance of recombination frequencies and their positions was > 99%.  
A typical MeioMap from a normal embryo-PB trio is shown in Fig 1d. This reveals 
Mendelian segregation of sequence polymorphisms (green and yellow segregate 2:2 across 
haplotype regions) and independent assortment of different chromosomes pairs in meiosis I, 
such that the haploid oocyte contains chromosomes of both yellow and green origin 
(pericentromeric SNPs are used as a chromosomes fingerprint). Crossovers, which result in 
recombinant chromosomes, are evident by transitions between the two maternal haplotypes 
(green or yellow) in the PB2 and oocyte, or between a single maternal haplotype and 
heterozygous regions (PB1). 39 cases of aneuploidy were detected by the absence or presence 
of SNPs from an entire chromosome (Table 1). The inferred chromosomal aneuploidies can 
be observed by array CGH (Extended Data Fig. S2). We also detected three gross structural 
rearrangements to chromosomes. Since two of the three meiotic products were affected 
(reciprocal gain and loss), it rules out that these rearrangements occurred during germline 
development and demonstrates that such rearrangements can occur during meiosis (Extended 
Data Table 3). Aneuploidy rates and the contribution of MI and MII errors were equally 
abundant and similar to those expected for this age range (33-41 years; Table 1)
13-17
.   
All gains and losses were reciprocal and involved two meiotic products, such that a 
gain in the oocyte was matched by the loss of the chromosome in the PB1 or PB2. Of the 529 
chromosome pairs assessed in the trios, we did not detect any deviation from the four 
chromatids expected to participate in meiosis. These observations firmly establish meiotic 
errors as the main contributor of aneuploid conceptions and do not support germline 
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mosaicism in chromosome number prior to meiosis
9
 as a significant factor in the maternal 
age-related increase in human trisomies. 
 
Reverse segregation: a novel chromosome segregation pattern in female meiosis. 
To understand the nature of missegregation, we inferred chromosome segregation from the 
trios by following the informative SNPs at the pericentromere. Trisomies that occur at a high 
rate in the natural population of women of advanced maternal age
4
 were originally 
hypothesized to arise by MI nondisjunction (MI NDJ) where both homologs segregate to the 
oocyte at meiosis I, followed by a normal second division
18
 (Fig. 2a, Extended Data Fig. S3a). 
However, cytological examination of human oocytes that failed to fertilise in IVF clinics 
suggested that precocious separation of sister chromatids (PSSC) was the major cause of 
human age-related trisomies
19
 (Fig. 2a, Extended Data Fig. S3b). Having the genetic identity 
of the chromatids not only from the embryos or oocytes but also their matched polar bodies 
allows the two segregation patterns to be distinguished, because the chromosome signatures 
in the two PBs will differ (Fig. 2a). Confirming previous studies using array CGH for copy 
number analysis in trios
20
, classical meiosis I nondisjunction was relatively rare and 
precocious separation of sister chromatids was more frequent (Fig. 2a-c). The preponderance 
of PSSC compared to meiosis I nondisjunction is consistent with findings in oocytes from 




Unexpectedly, the most frequent non-canonical segregation pattern gave rise to a PB1 
that contained two non-sister chromatids (green and yellow fingerprints around the 
centromere, n=26). In 20 of the 26 instances, both the oocyte and the PB2 contained a normal 
chromosome content, but with non-sisters instead of sister chromatids (Fig. 2a, Rev Seg). 
This pattern cannot be detected by copy number analysis used previously
20
, since the 
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complement of chromosomes in the three cells is normal (two chromatids in PB1, and one 
each in the oocyte and PB2). We refer to this novel pattern as reverse segregation, since we 
infer that sister chromatids of both homologs separated first in meiosis I, followed by non-
sister chromatids (homologs) in meiosis II (Fig. 2d). Both acrocentric and larger metacentric 
chromosomes displayed this reverse segregation pattern (Fig. 2c), which was observed in 
oocytes and embryos from all donors, ruling out that it was specific to certain women (Table 
2, Extended Data Table S4). In the remaining six cases, the two non-sister chromatids 
missegregated into the egg or the PB2, resulting in an aneuploid oocyte (Fig. 2a, Rev Seg MII, 
Extended Data Fig. S3d).  
There are several mechanisms that could contribute to the reverse segregation pattern. 
One intriguing possibility is that the reverse segregation pattern is the result of centromeric 
crossovers that fall at or within 1-2 Mb of the centromeres, the positions of the last 
informative SNPs (Supplemental Table S6). Centromeric crossovers interfere with 
segregation of sister chromatids in Drosophila
7
 and budding yeast
8
, and centromere-proximal 
crossovers are associated with an increased risk of aneuploidy in human foetuses
1
. Thus, the 
high incidence of MII nondisjunction (23%, n=26) could be explained by crossover at or 
within the extreme vicinity of centromeres. Another possible mechanism that seems 
particularly plausible for the larger metacentric chromosomes where two crossovers would 
have to occur within 1 Mb on both sides of the centromere, is that homologs segregated their 
sister chromatids in an equational fashion in MI, followed by a weak preference for accurate 
non-sister chromatid segregation at MII (77% compared to 50% expected from random; n=26; 
p < 0.05). The equational division at MI is unlikely to be the result of two independent PSSC 
events, because the observed frequency of both homologs separating their sister chromatids is 
more than 100× greater than the predicted frequency based on two independent PSSC events 
(p < 0.001). PSSC of one homolog could predispose the second homolog to split its sister 
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chromatids at anaphase I, or homologs could fall apart during the extended dictyate arrest to 
generate two univalents. There is some evidence for deterioration of bivalents into two 
univalents in human MI oocytes
21,22
 and this could predispose both univalents to segregate 
their sister chromatids at meiosis I. Indeed, this is the case in mouse oocytes, where 
univalents preferentially segregate sister chromatids at meiosis I
23,24
. In either case, at meiosis 
II, non-sister chromatids could be physically attached or the oocyte may use distributive 
segregation mechanisms that do not rely on physical attachment between chromosomes. The 
relative contributions of reverse segregation mechanisms and centromeric crossovers remain 
to be determined, but in either case demonstrate that events attributed to mistakes in 
chromosome segregation in meiosis II can have their origin at meiosis I in human female 
meiosis. 
 
Variation in global recombination rates in oocytes and embryos.  
Variation in recombination in foetal oocytes has been hypothesized to give rise to vulnerable 
crossover configurations that predispose chromosome pairs to missegregation decades later in 
the adult woman. To assess recombination in adult oocytes and embryos, we mapped 883 
maternal crossovers in the oocyte-PB trios and 1149 and 1342 maternal and paternal 
crossovers, respectively, in the embryos (Fig. 3a; note maternal rates could not be obtained 
for all embryos). 12% of the reciprocal crossover events occurred between non-sister 
chromatids in the PB2 and oocyte. A similar proportion would be expected to occur in the 
PB1 and are undetectable, since the two DNA strands cannot currently be separated and 
phased individually
10
. Using the 300K SNP arrays gave median resolutions of 107 Kb and 
331 Kb for crossovers in the oocyte-PB and embryos, respectively (Fig. 1e). This is similar to 





 Several observations support the conclusion that recombination rates in the adult 
oocytes and embryos are highly variable, like those seen in unselected, foetal oocytes
28-30
. At 
the same time, the average recombination frequencies are reminiscent of those reported for 
human populations. The average number of maternal crossovers in the oocyte or embryos 
was 41.6 ± 11.3 S.D.  (n=51 ; Extended Data Table 4; Supplemental Tables 1-5). This rate is 
consistent with estimates from foetal oocytes and population-based assessments
10,25,27,31-37
 
and those in detected in the female pronucleus (42.5 ± 9.0 S.D., n=52)
10
. The frequencies of 
crossovers detected in the egg correlated well with those in the PB1 or PB2 (Extended Data 
Fig. S4). The maternal recombination rates and the lengths of haplotype blocks were highly 
variable between donors as well as within donors
28,29,36,38
, varying by as much as two-fold 
(Fig. 3b, f and g; Extended Data Fig. S4). Using the oocyte-PB trios, maternal crossovers 
displayed a median distance of 32.4 Mb, which was in excess of the 18.3 Mb predicted by 
random distribution of crossovers along chromosomes (Methods). This is consistent with 
crossover interference along homolog pairs
10
.  
Embryos contain informative markers of both maternal and paternal origin. This 
allows us to assess recombination of both sexes in unselected embryos for the first time. 
Maternal recombination rates were 1.63-fold higher than paternal rates in the embryos, 
consistent with population-based studies and molecular approaches on single sperm and 
foetal oocytes
20,22,26-32
. The additional maternal recombination events tend to increase 
recombination on the X chromosome as well as larger chromosomes (Fig. 3d). Maternal 
recombination was more centromeric compared to paternal events (Fig. 3e, Extended Data 
Fig. S5), although centromeres tended to suppress nearby recombination
10,20,22,26-32
 (Fig. 3f). 
However, the suppression of centromeric crossovers varied amongst oocyte-PB trios, even 
within the same woman (Fig. 3g). This variation may predispose some oocytes to crossovers 
that are too near to centromeres that may interfere with segregation
1
. Collectively, these 
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observations reveal that the variation in total crossover numbers detected in adult oocytes is 
analogous to the variation in Mlh1 counts observed in foetal oocytes
28-30
, suggesting that 
Mlh1 foci serve as good proxy for crossover recombination events in human oocytes. 
Simultaneously, the average recombination rates are reminiscent of those in the human 
population. This validates our approach and lends support to the hypothesis that the 
variability in the rates and distribution of recombination events between and within 
individuals gives rise to vulnerable crossover configurations in foetal oocytes that are 
propagated to adult oocytes and, ultimately, embryos.  
 
Global recombination rates as a risk factor for aneuploidy. 
To understand how the variability of maternal recombination rates affects human aneuploidy, 
we addressed whether the global, genome-wide recombination rates were correlated with the 
incidence of aneuploidy in individual oocytes and embryos. Indeed, global recombination 
rate was a strong predictor of aneuploidy (Fig. 4a), even when we excluded an outlier embryo, 
which contained 12 aneuploidies and no detectable crossovers amongst any of the 
chromosome pairs. The recombination rate is an important factor, accounting for 18% of the 
variation in the incidence of aneuploidy (outlier excluded; permutation test).  
 If lower global recombination rates predispose oocytes to meiotic chromosome 
segregation errors, then normal euploid embryos should contain chromosomes that underwent 
higher maternal genome-wide recombination frequencies than those of aneuploid embryos. 
To examine whether this was the case, we divided the embryos and oocytes into two groups 
(euploid or aneuploid) and determined their respective recombination rates (Fig. 4b). Normal, 
euploid oocytes and embryos had on average, 5.8 recombination events more than aneuploid 
ones. This difference was significant even when we accounted for crossovers that may not be 





Notably, the overlap in the distribution of recombination rates between the euploid and 
aneuploid groups is consistent with the presence of other factors that influence the fidelity of 
chromosome segregation
1
. Our findings suggest that higher global recombination frequencies, 
which are determined during foetal development, protect against errors in chromosome 
segregation decades later in the adult woman. When errors do occur, they give rise to 
aneuploidy, many of which are selected against prior to the implantation of the embryo
39
. 
One implication of this is that recombination rates may be under selection in women as they 
enter their 30s, increasing rates by as much as 14% in women of advanced maternal age 
(5.8/41.5, the overall average). Elimination of aneuploid embryos that contain lower 
recombination rates could contribute towards the higher female-specific recombination rate 
observed in the human population. Since crossover frequencies are determined by the rate of 
initiation of double-strand breaks and the outcome of repair (crossover or noncrossover), 
mechanisms that alter either could be selected for in female meiosis. Notably, alleles that 
contribute to female-specific recombination rates have been identified in genome-wide 
association studies
35-38
and it has long been appreciated that chromosome structure is altered 
in female meiosis, with chromosomes having a longer axis and shorter chromatin loops
40
. 




    
 Non-recombinant chromatids are at risk of precocious sister chromatid separation at 
meiosis I.  
How do global recombination rates affect the segregation outcomes of individual homolog 
pairs? We hypothesized that lower global recombination rates might increase the risk of 
generating vulnerable crossover configurations. We first considered non-exchange E0 
homolog pairs, which would give rise to trios, where the PB1 contains one homolog (green or 
13 
 
yellow) and the oocyte and PB2 one sister each from the other homolog (Extended Data Fig. 
S6a). Of 529 chromosome pairs, no such example was observed in our data, although one 
case was observed by Hou et al. (Hou, pers. comm.). E0 may be extremely rare, or another 
possibility is that they missegregate. Indeed, we observed 13 presumed E0 from the 529 
chromosome pairs across the 23 trios (Extended Data Fig. S6a-d). The overall incidence 
(2.6%, n= 506) and the overrepresentation of the two smallest chromosomes (21 and 22) are 
reminiscent of observations of cytological markers for crossovers on foetal chromosomes in 
meiotic prophase
28-30
. The observed incidence of presumed E0 was much lower than expected 
if crossovers were randomly distributed amongst chromosomes (Extended Data Fig. S6h), 
suggestive of crossover assurance mechanism(s) in human oocytes. None of the presumed E0 
chromosomes followed a classical meiotic segregation pattern. Instead they all underwent 
PSSC or reverse segregation (with or without MII missegregation; Extended Data Fig. S6). 




 Informative SNPs on missegregated chromosomes cannot be phased, making 
crossovers undetectable (Extended Data Fig. S6). However, from the polar body analysis 
most of the presumed E0 contained non-recombinant chromatids (R0). Fig. 4c shows that 
global recombination rates are important for determining the generation of R0, which in turn 
are at increased risk of missegregation compared to fully recombinant bivalents (all four 
chromatids engaged in recombination; rec, Fig. 4d). Bivalents that contained a R0 were 
preferentially involved in PSSC, suggesting that non-recombinant chromatids are at risk of 
precociously separating from their sister at meiosis I. It is possible that non-recombinant 
chromatids are at elevated risk of becoming dissociated from the rest of the bivalent during 
the decades-long dictyate arrest
41,42
. We conclude that recombination affects not only the 
14 
 
generation and segregation of putative non-exchange homolog pairs, but also influences the 
dynamics of sister chromatid segregation.  
 
Meiotic drive for recombinant chromatids at meiosis II.  
Recombination does not only affect segregation of sister chromatids at meiosis I, but also at 
meiosis II. The MeioMaps revealed 135 chromatids in the oocyte or PB2 that were non-
recombinant and had segregated normally (Fig. 5a). These R0 are expected to be randomly 
distributed amongst the oocyte and the PB2. Contrary to this expectation, R0 were nearly 
twice as likely to be found in the PB2 than the oocyte. The selection appears to be against 
non-recombinant chromatids, because when both sisters recombined, their segregation was 
random and the recombination rates were similar in the oocyte and PB2 (Extended Data 
Table 4). We infer that when the two sister chromatids segregated at meiosis II, non-
recombinant chromatids were preferentially driven into the PB2 and thus eliminated from the 
human germline (Fig. 5b,c). The use of the asymmetric cell divisions during oogenesis for the 
preferential inclusion of an allele
43
 or even whole chromosomes
44-46
 is referred to as meiotic 
or chromosomal drive. The meiotic drive against non-recombinant chromatids resulted in a 
6.6% elevation in the recombination rates in oocytes compared to the PB2s (Extended Data 
Table 4). These findings imply that recombination is not only important for the accurate 
segregation of homologs at meiosis I, but also acts as a driving force during sister chromatid 
segregation at meiosis II. Selection against non-recombinant chromatids may prevent entire 
chromosomes from being inherited as a single haplotype block, thereby reducing the 
probability of inbreeding or propagation of segregation distorters
47-49
. This may be significant 
in terms of population structure and the genomic health of children. The difference in genome 
structure between the PB2 and oocyte is particularly relevant, because the PB2 has been 







Until recently, recombination was studied in populations, where missing polar body 
information was not available; or in foetal oocytes, which arise decades prior to the 
segregation events being studied. MeioMaps from unselected adult oocytes, the female 
pronucleus in zygotes
10
, and embryos, now provide a missing link between events that 
occur during foetal development and their influence on chromosome segregation outcomes 
decades later in the adult oocyte. MeioMaps provide compelling evidence that the high 
degree of variation in recombination rates between and within women is conserved from 
foetal to adult oocytes
28-30
 and in conceptions
10
 (Fig. 3). This implies that the oocytes remain 
relatively unselected in terms of recombination rates throughout development, which includes 
the severe phases of atresia during which > 96% of foetal oocytes are culled prior to 
adulthood. Our findings show that it is this broad variation that leads to lower recombination 
rates in some eggs, which in turn predispose to them to aneuploidy decades later. Lower 
genome-wide recombination rates increase the risk of generation of at least two types of 
vulnerable crossover configurations: non-recombinant chromatids (R0) and putative non-
exchange homologs (E0). It follows that mechanisms that regulate the distribution of 
crossovers amongst chromosome pairs (crossover assurance) and between sister chromatids 
potentiate the risk that lower recombination rates exert on the generation of such vulnerable 
crossover configurations.  
We found recombination rates explained a significant portion of the variation in 
aneuploidy (18%), whereas another study of younger donors found a weaker contribution
10
. 
How age and recombination interact to influence segregation of chromosomes, including 
reverse segregation and meiotic drive against non-recombinant chromatids, is currently 
unclear as oocytes from younger donors did not show these features
10
. Findings from several 
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population studies are consistent with the interpretation that higher genome-wide 
recombination rates are important for chromosome segregation  and fertility
26,33,35,51
 and 
become increasingly important as women age
25,33
. Our observations suggest that higher 
recombination rates protect the oocyte against aneuploidy in women of advanced maternal 
age, which are therefore more likely to give rise to an euploid conception and live birth.  
Several genome-wide association studies have identified variant SNPs that affect maternal 
recombination rate 
33,35,38,51
. It is conceivable these could be used as biomarkers to stratify 
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Table 1. Origin and incidence of maternal aneuploidies. 



















MI MII MI MII 
Oocyte-
PB trios 
37.3       
(33-41) 
13 62% 26 12 2 4 4 2 299 
Embryo-
PB trios 
38.3 10 70% 19 8 4 1 0 3 230 
Embryo 
only  
37.1       
(34-42)    
29c 54% n.d. 19 5 4 n.d n.d. 667 
a Mean age and range. 
b Number of trios or embryos analysed 
c28 embryos and 1 chorionic villus sample. 
dStatistical test for significance of MII nondisjunction rates in oocyte-PB and embryo-PB trios: 6 out of 299 
compared to 4 out of 230, respectively, G-test with Williams correction, p = 0.82. 
n.d., not determined since no information from polar bodies. 
 
Table 2. Incidence of reverse segregation 
Sample type Incidence Chromosomes involved 
Oocyte-PB1 duos (unactivated)a 8.7 ± 4.2% (n=46)     4, 13, 14, 16 
Oocyte-PB1-PB2 trios 3.7 ± 1.1% (n=299)     4, 11, 14, 15, 16, 19, 22 
Embryo-PB1-PB2 trios 7.2 ± 1.8% (n=207)     4, 9, 16, 17, 19, 21, 22 










Figure 1. Human MeioMaps from embryos and oocytes together with their corresponding 
polar bodies. Combined recombination and chromosome segregation patterns were inferred 
by retrieving and SNP typing all three meiotic products from single meioses.  
(a,b) The two maternal chromosomes and their genotypes are shown in green and yellow, 
respectively. Crossovers in the primary oocyte occurs during foetal development and are 
shown in the dashed box. The two polar bodies were sequentially biopsied to avoid 
misidentification (shown by grey vertical arrows). Maternal MeioMaps were deduced from 
the embryo following intracytoplasmic sperm injection (ICSI) or directly assessed in the 
haploid oocyte, after artificial activation (b).   
(c) Example of an activated oocyte with a single pronucleus (arrow) and extruded PB2. 
(d) An example of a MeioMap from a normal meiosis after individual processing of the three 
cells following MDA amplification, genome-wide SNP detection, and phasing (see Methods). 
Each chromosome is represented by three vertical columns of the three cells of the trio (PB1, 
PB2, and embryo or oocyte). The two maternal phased haplotypes are represented by green 
and yellow. Blue represents the detection of both haplotypes. Regions where SNPs are not 
available on the array are shown in white (repetitive sequences on chr. 1 and 9) or gray 
(rDNA). Black bars illustrate the position of the centromere. Red bars shows the last 
informative SNPs to call. Crossovers are manifested as reciprocal breakpoints in haplotypes 
(green to yellow, blue to green, etc.) in two of the three cells. Note that the colours of the 
haplotype blocks between different chromosomes are not necessarily derived from the same 
grandparent. Histograms of the resolution of the crossovers are shown in  
(e). The resolution was 352 Kb and 311 Kb for maternal (m) and paternal (p) crossovers in 




Figure 2. MeioMaps reveal origin of aneuploidies and a novel chromosome segregation 
pattern.  
(a)  Segregation patterns revealed from following the pericentromeric haplotypes (yellow and 
green around centromere) in all three products of female meiosis. Only examples leading to 
trisomic conceptions are shown. For all possible segregation patterns detected by 
Meiomapping see Extended Data Figure S3. MI NDJ: meiosis I nondisjunction; Rev Seg 
reverse segregation; PSSC: precocious separation of sister chromatids; MII NDJ: meiosis II 
nondisjunction. 
(b) Incidence and type of segregation errors in oocyte-PB and embryo-PB trios. Errors 
detected in MeioMaps generated from the female pronucleus (FPN-PB) from a younger 
donor population
10
 are shown for comparison The number of donors and average (av.) age 
are shown. Age ranges were 25-35for FPN-PB
10
 and 33-41 for oocyte-PB trios (Extended 
Data Table 2). The embryo donor was 38 years of age (Extended Data Table 1). 
(c) Chromosome abnormalities that resulted in aneuploid oocytes or embryos (upper panel) 
and all non-canonical segregation patterns (lower panel). 
(d,e) Inferred mode of reverse segregation (Rev Seg) and detection of the unactivated 
intermediate (oocyte-PB1 duo, e) . Frequencies are shown in Table 2. Alternative segregation 
outcomes at meiosis II (euploid and aneuploid, n=26; p < 0.025; binomial exact test with 
correction for continuity). 
 
Figure 3. Variation in genome-wide recombination rates between and within individuals. 
(a) Boxplot of global recombination rates for oocyte-PB trios, oocytes only, embryo-PB trios 
and embryos only (maternal and paternal). Note that maternal recombination rates are 1.6-
fold higher than paternal rates. On the right, the boxplot shows global recombination rates for 
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foetal oocytes at the pachytene stage as measured by Mlh1 foci
30
 (Gruhn) and for female 
pronucleus-PB trios from adult Chinese donors
10
 (Hou).  
(b) Global recombination rates for the 10 donors used in this study. Black circles denote 
maternal recombination rates for oocyte or embryo only whereas magenta circles show 
maternal recombination rates for complete oocyte-PB (donors: G04, G06, G07, G08, G09) 
and embryo-PB trios (LB03).   
(c) Distribution of distances between crossovers (Mb).The simulated median distance based 
on random distribution is 18.3 Mb (Methods). The fitted curve is based on maximum 
likelihood estimation of a gamma distribution, with shape 2.6141 ± 0.14 (S.E.) and rate 0.066 
± 0.0039 (S.E.). The estimated mean for this fit is 39.3 Mb. Log-likehood of fitting: -
2802.738 ; AIC:  5609.476. Centromeric distances were not included from the inter-crossover 
distances that spanned centromeres. (d) Average maternal and paternal recombination events 
on a chromosome-specific basis (embryos; Supplemental Table S1). Error bars denote the 
standard deviation. GLM analysis revealed that chromosome size had a significant effect on 
sex-specific recombination frequencies. Spearman correlation test is shown for the p-value 
for individual, pair-wise comparisons between maternal and paternal recombination 
frequencies per chromosome. As chromosome size decreases, the contribution of sex to 
crossover frequencies decreases (Supplemental Raw Data, Fig. 3d).  
(e) Crossover position relative to centromeres (CEN), normalized to chromosome length. 
Statistics: Two-sided Kolmogorov-Smirnov test of normalized length (shown) and absolute 
length; p < 0.0005) after removing the X chromosome. Absolute lengths are shown in 
Extended Data Fig. S5. 
(f) Length of haplotype blocks (not inter-crossover distances), classified according to location 
relative to telomeres (blue), spanning centromeres (light red), or interstitial (green). Statistics: 
non-parametric ANOVA for type (telomeric, centromeric or interstitial; p < 0.0001). The 
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distances that included a centromere were not adjusted to include the ~ 3 × 10
6
 base pairs of 
alpha-satellite DNA. 
(g) Variation in centromere repression of crossovers in oocyte-PB trios from the same donor. 
 
Figure 4. Higher global recombination rates protect against aneuploidy and are selected for 
in the human female germline.  
(a) Logistic regression of the frequency of aneuploid chromosomes as a function of global 
recombination rate in the embryo or oocyte. Black lines shows logistic regression model and 
95% confidence interval (dashed line; binomial family). When the outlier with 0 
recombination events was omitted, the regression coefficient ȕ was -0.06 and still highly 
significant (p < 0.003).  The outlier was omitted from all subsequent statistical analyses.  
(b) Recombination rates in normal versus aneuploid oocytes and embryos. The arithmetic 
mean is shown above of the median (magenta, vertical bar). Statistics: Mann-Whitney-
Wilcoxon test; one-sided. 
(c) Incidence of bivalents containing at least one non-recombinant chromatid (R0) as a 
function of global recombination rates in oocyte-PB and embryo-PB trios. Statistics as in (a). 
(d) Segregation errors amongst chromosomes that contained one or more R0 or where all four 
chromatids had recombined (rec) . p-values from G-test of heterogeneity (two-sided) are 
shown. 
 
Figure 5. Meiotic drive for recombinant chromatids at meiosis II increases recombination 
rates in the human female germline.  
(a) Sister chromatids are expected to segregate randomly at meiosis II. However, when 
chromosomes that contained one non-recombinant chromatid and one recombinant one 
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segregated, the recombinant chromatids was twice as likely to segregate to the oocyte. G-test 
for proportions (two-sided). 
(b) Number of R0 chromosomes segregating to PB2 or oocyte 
(c) Diagrammatic representation of meiotic drive for  recombinant chromatids at meiosis II in 
the human female germline. 
 
Extended Data Figure Legends 
Extended Data Fig. S1. Phasing of maternal haplotypes. Maternal informative SNPs are 
phased using the assumed ancestor method
10
. A haploid cell containing a single chromatid 
(1C; either PB2 or Egg) is chosen as the assumed ancestor or reference. Trios from the 
same mother (or father) are assumed offspring. Using the reference, crossovers in all other 
assumed offspring are mapped where haplotypes changes compared to the assumed ancestral 
phasing. Crossovers shared between sibling trios (or assumed offspring; red boxes) can be 
used to infer crossovers in the assumed ancestor. Iterative phasing using all available oocytes 




Extended Data Fig. S2. Validation of whole chromosome aneuploidy by array CGH. 
An example of chromosome segregation abnormalities inferred from the SNP array patterns 
in oocyte-PB trios and confirmed by array CGH of the same amplified DNA from all three 
samples. The green and pink lines are the internal female sample and the blue trace indicates 
the male reference. The log2 ratio of the X chromosomes of the reference genomes are used 
as internal calibration of whole chromosome loss or gain. The MeioMaps for three 
chromosomes in the same oocyte-PB trio are shown below the aCGH traces (G04_1). For 
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chromosome 13, three chromatids segregated to the first polar body, a single chromatid was 
present in the second polar body and none in the oocyte. This is consistent with precocious 
separation of sister chromatids (PSSC) at meiosis I. Chromosome 20 segregated normally at 
meiosis I (normal PB1), but there was a gain in the oocyte and corresponding loss in PB2, 
consistent with a meiosis II nondisjunction. Chromosome 22 underwent a partial gain in PB1 
and corresponding loss in the oocyte. This is consistent with a gross structural rearrangement 
whereby the majority of chromosome 22 segregated to the PB1 along with the intact homolog 
(Extended Data Table S3). In the SNP representations, yellow and green blocks represent the 
two different grandparental haplotypes and blue regions denote regions where both 
haplotypes are present. All aneuploidies in the oocyte-PB trio dataset were verified using 




Extended Data Fig. S3. Non-canonical segregation patterns-. 
(a) Meiosis I nondisjunction yields a PB1 containing all four chromatids and empty oocyte 
and PB2 (upper panel); or an empty first polar body and two non-sister chromatids in the 
oocyte and PB2 (lower panel).  
(b) Precocious separation of sister chromatids (PSSC) has four possible segregation outcomes 
(i – iv). The green homolog has separated precociously at meiosis I and the yellow homolog 
segregates normally either to the oocyte (top panel) or the PB1 (lower panel). At meiosis II, 
the green chromatid segregates randomly to the oocyte (i) and (iii), or to the PB2, (ii) and (iv). 
Note that one of the nine PSSC involved a structural change in combination with the 
precocious separation of the sister chromatids in meiosis I. 
(c) Meiosis II nondisjunction results in two sister chromatids in either the oocyte or PB2 
(shown for green only). This pattern could also arise from an earlier PSSC event, where the 
two sister chromatids have come apart and both stay in the oocyte at meiosis I. 
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(d) Reverse segregation. Both homologs segregate their sister chromatids at MI, giving rise to 
an intermediate where both the oocyte and PB1 contains the correct content, but two different 
sister chromatids (Figure 2e). At meiosis II, the two non-sister chromatids either segregate 
into the PB2 and oocyte; remain in the oocyte, or both segregate to the PB2 (Fig. 2d). Dotted 
boxes highlight three different segregation errors that would give rise to the same pattern of 
maternal pericentromeric SNPs in a trisomic conception (i.e. two non-sister chromatids). 
Without the information from the polar bodies, these three patterns  are indistinguishable. 
 
 
Extended Data Fig. S4. Correlation of recombination detected in the oocytes and polar 
bodies.  
 (a-c) Spearman correlation (ρ) between crossover frequencies per meiosis estimated from the 
oocyte-PB trio and correlated with counts in PB1 only (a), oocyte only (b), and PB2 (c). 
(d) Correlation of crossover events detected in the oocyte compared to the PB2. (n= 13; 5 
donors).  
 (e) Heterogeneity in haplotype lengths in the five different oocyte-PB donors. 
 
Extended Data Fig. S5. Chromosome-specific responses to recombination rates and 
positions in male and female meiosis. 
(a) Density curves of the normalized distance of crossovers to centromeres (CEN). Statistics: 
Kolmogorov-Smirnov test, two-sided. 
(b,c) Histograms and density curves of absolute distances of crossovers to centromeres. 
Statistics: Kolmogorov-Smirnov test, two-sided. 





Extended Data Fig. S6. Crossover assurance in human female meiosis. 
 (a) A non-exchange or exchange-less chromosome pair (E0) (left). In normal meiosis, non-
exchange chromosome pairs can be detected by a single haplotype in the PB1 and the other 
haplotype in the oocyte and PB2.  
(b) E0 that undergo reverse segregation (b) cannot be detected directly. This is because the 
informative SNPs on the two chromatids in the PB1 cannot be phased, hence potential 
crossovers (far right) cannot be detected.  
(c) PSSC can result in three chromatids in the PB1. Both maternal SNPs will be present along 
the entire chromosome (blue). Reciprocal crossovers cannot be mapped, hence the lack of 
crossovers can only be presumed. 
(d-g) Trios with chromosomal content consistent with presumed exchange-less (E0) homologs 
due to reverse segregation (RS) resulting in two aneuploid cells (d), reverse segregation 
resulting in normal chromosomal content in all three cells (e), precocious separation of sister 
chromatids (PSSC) with an aneuploid (f) or euploid oocyte (g). 
 (h) Modelled risk of a chromosome pair failing to receive a crossover (E0) as a function of 
global recombination rates, using the range of rates observed in our datasets. Crossovers were 
allocated randomly to chromosomes with weighted probability using the chromosome length, 
thus longer chromosomes receive more crossovers. Data are from 10,000 simulations (see 
Extended Methods).  
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EXTENDED DATA TABLES  
File name: Extended Data Tables 
Extended Data Table 1. Donor information of  embryos. 
Extended Data Table 2. Donor information of oocyte-PB trios. 
Extended Data Table 3. Structural rearrangements to chromosomes in meiosis. 
Extended Data Table 4. Summary of recombination and chromosome segregation in all trios. 
 
RAW DATA & SUPPLEMENTAL DATA 
Raw data for Figures where required. Data for subpanels are included in separate 






Fig_S4_RawData.xlsx (Extended Data Fig. S4) 
Fig_S5_RawData.xlsx (Extended Data Fig. S5) 
Fig_S6_RawData.xlsx (Extended Data Fig. S6). 
 
SUPPLEMENTAL DATA TABLES: 
Ottolini_SupplementalTables.xlsx  
Contains: 
Supplemental Table 1 : Recombination frequencies in embryos 
Supplemental Table 2 : Map distances in embryos 
Supplemental Table 3 : Crossovers in oocytes 
32 
 
Supplemental Table 4 : Recombination frequencies in oocytes 
Supplemental Table 5: Map distances in oocytes 
Supplemental Table 6: hetSNP or informative SNP resolution near centromeres  












Patient participation and consent 
All MII oocytes for the study were obtained from patients undergoing ICSI treatment in the 
Centre for Reproductive Medicine GENERA in Rome between 2 September 2008 and 15 
May 2009 following controlled ovarian hyperstimulation performed using two different 
protocols: GnRH-agonist long protocol and GnRH-antagonist protocol. According to the 
Italian law in force when these oocytes were collected, a maximum of three oocytes could be 
inseminated per patient. The remaining MII oocytes were vitrified and later recruited for the 
study after informed consent was obtained from the patients. The study and the informed 
consent were approved by the Institutional Review Board of the Valle Giulia Clinic and did 
not influence patient treatment. 
 
Oocyte collection 
Oocyte collection was performed at 35 h post-hCG administration. Removal of the cumulus 
mass was performed by brief exposure to 40 IU/ml hyaluronidase solution in Sage 
fertilization medium + 10% human serum albumin (HSA) (Cooper Surgical, USA), followed 
by mechanical removal of the corona radiata with the use of plastic denuding pipettes of 
defined diameters (COOK Medical, Ireland) in a controlled 6% CO2 and 37°C environment. 
This procedure was performed between 37 and 40 h post-hCG administration. MII oocytes 
were then identified for vitrification. 
Oocyte vitrification and warming 
The vitrification and warming procedures were performed according to Kuwayama et al. 
52,53
. 
Commercially available vitrification and warming kits were used (Kitazato BioPharma Co., 
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Japan). The vitrification procedure was performed a maximum of 40 hours post hCG 
administration. The oocytes were stored on a cryotop vitrification tool (Kitazato BioPharma 
Co., Japan) with a plastic cap for protection during storage in liquid nitrogen. All oocytes 
were stored submerged in liquid nitrogen until warming was performed. Following oocyte 
warming degenerated oocytes were discarded and the surviving oocytes were cultured before 
biopsy of the first polar body (PB1) and activation. 
 
Oocyte culture and activation 
All oocyte culture was performed at 37°C in 6% CO2 and 5% O2. To enable tracking of the 
oocytes and PBs, individual culture was performed and culture drops and wells were 
numbered to allow traceability throughout the experiment. 
Immediately after warming, the surviving oocytes were allocated to individually 
numbered 35 µl microdrops of Sage cleavage medium + 10% HAS under mineral oil (Cooper 
Surgical, USA)  and cultured for 2 hours prior to PB1 biopsy and activation.  
Oocytes were activated by exposure to activation medium: 100 µM calcium 
ionophore (A23187, C7522 Sigma-Aldrich) in Sage cleavage + 10% HSA (Cooper Surgical, 
USA) from a stock solution in DMSO (Sigma-Aldrich) diluted 1:40. Oocytes were 
transferred to 35 µl drops of the activation medium under Sage oil, numbered appropriately. 
Activation culture was performed for 40-120 mins. The oocytes were then moved to post 
activation culture. 
Post activation culture was performed in separate wells of EmbryoScope slides 
(Unisence Fertilitech, Denmark) in cleavage medium - medium as used in post warm culture 
under Sage oil. The slides were placed in the EmbryoScope time lapse incubator (Unisence 
Fertilitech, Denmark) for assessment of second polar body (PB2) extrusion and appearance of 




Polar body biopsy 
Polar bodies were biopsied sequentially in order to discriminate between the 3 products of 
meiosis using micromanipulators (Narishige, Japan) on an inverted microscope (Nikon Ltd, 
Japan) equipped with Hoffman Modulation contrast and a 37°C heating stage (Linkam 
Scientific Instruments, UK). The first polar body (PB1) was biopsied prior to oocyte 
activation and the second polar body (PB2) was biopsied following its extrusion, post 
activation as previously described by Capalbo et al.
16
. All biopsies were performed in 
individually numbered 10 µl microdrops of HEPES medium + 10% HSA under Sage oil 
(Cooper Surgical, USA) for tractability. For both PB1 and PB2 biopsies, oocytes were 
positioned on the microscope to give a clear view of the PB and secured by suction with the 
holding pipette (TPC, Australia). An aperture was made in the zona pelucida with a series of 
laser pulses (Saturn laser; Research Instruments, UK) working inwards from the outer surface 
of the zona. The aspiration pipette (zona drilling pipette; TPC, Australia) was then inserted 
through the opening and the PB removed with gentle suction. PB1 biopsy:  Once biopsied the 
oocytes were moved to activation culture leaving the biopsied PB1 in the microdrop for 
immediate transfer to a 0.2 ml, RNase and DNase free thin walled, flat cap PCR tube 
(Corning, Sigma-Aldrich) for DNA amplification. PB2 biopsy: once biopsied the PB2 was 
immediately transferred to a PCR tube for DNA amplification with the oocyte still in the 
microdrop. The oocyte was then returned to the micromanipulator for full zona removal. The 
zonae were removed from the oocytes using the same setup for the biopsy procedure. The 
oocyte was anchored to the holding pipet and a larger aperture was made in the zona using 
laser pulses. The oocyte was removed from the zona using both displacement and zona 
manipulation techniques with the aspiration pipette. Once free from the zonae, the oocytes 
were transferred to PCR tubes for DNA amplification. 
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Transfer of the samples to PCR tubes was performed using a plastic denuding pipette 
(COOK Medical, Ireland) with a 130 ȝm lumen.  Individually labelled PCR tubes were 
primed with 2 ȝl Dulbecco's phosphate buffered saline (DPBS) (Gibco, Life technologies) 
with 0.1% polyvinyl alcohol (Sigma-Aldrich). Individual samples were expelled into the 
DPBS in around 1 ȝl of the medium containing the samples, leaving a final volume of no 
more than 4 ȝl of medium with the sample in the PCR tubes. The PCR tubes were then 
briefly centrifuged, snap frozen in liquid nitrogen and stored at -20 °C prior to whole genome 
amplification. 
 
DNA extraction and Whole Genome Amplification (WGA) 
Genomic DNA (gDNA) from all oocyte donors was obtained using buccal cell swabs 
(Isohelix, Cell Projects Ltd). Extraction of the gDNA from the swabs was performed using a 
proteinase K extraction kit to a final volume of 30 µl, following the manufacturers 
instructions. DNA from all three products of meiosis was obtained by lysis of the cells and 
whole-genome amplication (WGA). The PCR tubes containing the samples were brought to 
an end volume of 4 ȝl with PBS and REPLI-g Single Cell Kit multiple displacement 
amplification (SureMDA, Illumina) or PCR library based SurePlex amplification (Illumina) 
was performed according to the manufacturers instructions. MDA was performed with a 
short 2h incubation.  
 
Embryos and embryo-PB trios 
Embryo samples 
Thirty five embryos diagnosed as affected and/or aneuploid were analysed from four clinical 
cases for either preimplantation genetic diagnosis (PGD) of single gene defects or 
preimplantation genetic screening (PGS) for aneuploidy following standard IVF protocols at 
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The Bridge Centre, London with patients informed consent. SNP genotyping was performed 
for quality control purposes following clinical biopsy and genetic testing of the embryos 
under the HFEA clinic licence L0070-14-a using similar methods to those described for the 
processing of the oocyte-PB trios.  
In one of the PGD cases, two surplus denuded MI oocytes were allowed to mature in 
vitro by overnight culture in Sage fertilisation medium +10% HSA under mineral oil (Cooper 
Surgical). Biopsy of PB1, tubing and WGA of the oocyte and PB1 were then performed as 
described for the oocyte-PB trios. 
 
Embryo-PB trios 
In another PGS case, in which array CGH had been used to detect aneuploidy by copy 
number analysis of both polar bodies, the WGA products (Sureplex; Illumina, San Diego, 
CA, USA) from both polar bodies were SNP genotyped along with parental genomic DNAs 
and, with patients informed consent, WGA products (SureMDA; Illumina, San Diego, CA, 
USA) of nine corresponding fertilised embryos which had all been diagnosed as aneuploid.  
 
Array CGH, SNP bead array and data analysis 
For array CGH analysis, 4 µl aliquots of Sureplex single cell amplified DNA Products (PB1, 
PB2, oocyte or blastomere) were processed on  microarray slides (24Sure; Illumina, USA). 
The data was imported and analysed using dedicated softwaresoftware (BlueFuse Multi v 4.0; 
Illumina, USA). 
  For SNP genotyping, 400 ng of genomic DNA or 8 µl of WGA products from the 
single cell and embryo samples (PB1, PB2, oocyte, single blastomere or whole embryo) were 
processed on a  SNP genotyping beadarray (Human CytoSNP-12 or Human Karyomapping 
beadarray; Illumina, San Diego, CA, USA) for ~300K SNPs, using  a shortened protocol and 
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the genotype data analysed using a dedicated software programme for karyomapping 
(Bluefuse Multi v 4.0; Illumina, San Diego, CA, USA) or exported as a text file for analysis 
in Micrsoft Excel
12
.   
 
MeioMap analysis 
Following SNP genotyping, MeioMaps were constructed and displayed by importing the data 
into Microscoft Excel and processing using custom macros written in Visual Basic for 
Applications. For the oocyte-PB trios, a simple algorithm was used to phase all heterozygous 
maternal  SNP loci using a haploid PB2 or oocyte sample as a reference. This defined a 
reference set of homozygous SNP loci (haplotype) genome wide (AA or BB), across each 
chromosome. The genotype of each of the samples including the reference were then 
interrogated at each of these informative SNP loci and displayed as either the same as the 
reference (yellow) or opposite to the reference (green) or heterozygous (blue) indicating the 
presence of both maternal haplotypes. Phase transitions at crossovers were then manually 
tagged in Excel by copying the closest SNP calls bracketing the crossover and the type and 
position of these SNPs imported into a second spreadsheet for further processing. Because 
phasing is achieved using a reference sample, any phase transitions caused by crossovers in 
that particular sample appear in identical positions in all other samples analysed (with the 
exception of any crossover between the reference and the PB2 or oocyte in that trio). Macros 
in the second spreadsheet therefore identified these common crossovers, restored them to the 
reference sample and removed them from all of the other samples. The meiomaps were then 
displayed, checked and further edited manually as necessary. All oocyte-PB trios were run 
with at least two references to MeioMap any aneuploid chromosomes in the reference trio 
and to double-check all crossovers. 
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 For embryo-PB trios, two methods were used. Where the SNP genotype of a close 
relative or, in some cases, a sibling embryo was available, the samples were karyomapped 
using the standard algorithm which identifies informative SNP loci for all four parental 
haplotypes in either Excel or using dedicated software (Bluefuse Multi v 4.0; Illumina, San 
Diego, CA) 
11,12
. Alternatively to improve resolution, a modified karyomapping algorithm, 
with a PB2 or oocyte as reference, was used. This algorithm identified all combinations of 
parental genotypes that were informative for the maternal haplotype only. In either case, the 
phase transitions were manually tagged and imported into the second spreadsheet for further 
processing, display and final editing as above. 
 We validated our workflow on single cells by comparing recombination maps in 15 
individual cells from a donor to the genomic DNA of the child, and by assessing 10 
individual blastomeres from the same embryo for direct comparison. In all cases, 
concordance of recombination rates and positions was >99% (data not shown).  
 
Simulation: crossover distribution amongst chromosomes and distances between 
crossovers along chromosomes. 
12% of crossovers occurred between the PB2 and oocyte and a similar proportion would be 
expected to occur in the PB1, which go undetected since the heterozygous SNPs (blue 
regions) cannot be phased.  
Maternal recombination rates in the oocyte-PB and embryo-PB trios were similar to 
those reported from foetal oocytes
28-30
 as well as female pronucleus-PB trios from young 
women
10
. When only the embryo or oocyte was used, >50% of crossovers went undetected in 
the two polar bodies (Fig.3a-b) . The recombination rates in the oocyte or embryo correlated 
well with those discerned from polar bodies (Extended Data Figure S3). This supports the 
notion that recombination occurs randomly amongst non-sister chromatids. Indeed, when 
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homolog pairs had engaged in crossing over twice, no evidence of increased or decreased 
probability of the same two chromatids engaging in the second crossover was detected 
(Methods). This is consistent with reports that the preference for two sister chromatids to re-
engage in a second crossover given their involvement in the first (negative chromatid 
interference) is very weak
10
. 
 Simulations were performed to allocate a specified number of crossover events to 
set of chromosomes. Chromosomes were allocated a specified length using the minimum and 
maximum crossover locations mapped within the experimental dataset. Crossovers were 
allocated randomly to chromosomes with weighted probability using the chromosome length, 
thus longer chromosomes receive more crossovers. The allocation was either totally random 
(non-obligate) or random following allocation of one crossover per chromosome (obligate). 
For each chromosome the positions of the allocated crossovers was determined iteratively by 
randomly selecting an available location. The available locations were all possible positions 
not within a minimum distance (107 kb) from the existing crossover positions. The 
simulation reported the total number of crossovers per chromosome and the inter-crossover 
distances. The  distance from the outermost crossover to the chromosome termini was not 
included. 10,000 simulations were performed to create the distributions. The scripts 
(Ottolini_Scripts_CrossoverData.pl) are freely available under copyright and GNU public 
licence. 
 To estimate the fraction of missed crossovers, we randomly distributed 125 crossovers 
amongst chromosomes with a minimum distance of 0 kb between them 
(Ottolini_Scripts_CrossoverData.pl). A cumulative distribution of inter-crossover distances 
was constructed, ignoring crossover distances that were adjacent to telomeres. The 
cumulative frequencies was 0.04% at 10 kb, 0.15% at 30 kb, 0.52% at 107 kb, 0.75% at 150 





To detect chromatid interference, we identified 134 chromosome pairs with two crossovers 
and we asked whether the same two chromatids were less or more likely to be involved in 
both crossover events compared to random participation. We were unable to reject the null 
hypothesis of no chromatid interference (p > 0.5; t-test for proportions), consistent with 




Statistics, modelling, and graphics. 
Statistical tests and modelling were carried out in Perl or R. All tests were permutation and 
non-parametric tests, or logistic regression analysis as indicated throughout the manuscript. 
For logistic regression, we used the AIC to choose the appropriate link function. Binomial 
distribution of error variances were assessed using the plot(model) function of R. Residual 
variance and degrees of freedom was tested using chi-square and rejected if below 5%. Two-
sided tests were employed, unless otherwise indicated. We used the lme4, lmPerm, psperman 
libraries in R. Graphics were rendered using the basic functions in R or the ggplot2 library
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Cleavage  Morula Blastocyst 
LB01 38 8 4 2 1 1 no 1 Live birth 
PGD for single gene 
disorder and PGS for 
advanced maternal age 
LB02 35 10 6 2 0 4 no 2 Twin live birth 
PGD for single gene 
disorder 
LB03 38 21 10 5 1 4 9 1 None PGS for recurrent 
miscarriage 
LB04 34 23 8 5 3 0 no 1 None PGD for paternal translocation 
LB05 41 27 10 10 0 0 no 1 Live Birth PGS for advanced 
maternal age 
Total: 38       9 5 3 
 
 
aFrom The Bridge Centre, UK. Diagnostic follow-up in compliance with the code of practise (HFEA). 
bDonor of the two MII-arrested oocyte-PB1 duos (see Methods). 
cCorresponding embryo with both polar bodies analysed for MeioMapping. 
dembryo giving rise to live births not mapped. 



























G01 10 10 4 4 2 0 37.4 no idiopathic 
G02 6 3 3 3 3 0 36.2 yes male factor 
G03 15 10 10 5 3 0 37.6 yes male factor 
G04* 11 5 5 5 5 3 35.7 no male factor 
G05 11 6 3 3 3 0 37.3 yes idiopathic 
G06* 12 6 6 5 4 4 40.6 yes male factor 
G07* 16 9 6 6 5 1 38.4 yes tubal 
G08* 10 7 5 5 5 3 37.9 yes endometriosis 
G09* 12 fresh 2 2 2 2 33.2 yes male factor 
G10 18 18 3 2 2 0 39.0 no male factor 





*trios used to generate MeioMaps. Average age: 37.2 years. 
  
Extended Data Table S3. Structural rearrangements to chromosomes in meiosis  
 
Donor ID Chromosome Breakpoint position (Mb) Description 
G04_1* 22q 18.6 Mb Loss of large section of q-arm in oocyte, reciprocal gain in PB1 
G04_3* 8p 9.6 Mb Gain of small region at p-Ter in oocyte, reciprocal loss in PB1 
G09_2* 15q 44.1 Mb Gain of region of q-arm in oocyte, reciprocal loss in PB1 
LB03_13** 4q 83.07 Mb Deletion of large region in PB2 only 














  chromosome 
Total 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X 
G04 3 
PB1 6 4 4 3 3 2 3 3 3 3 2 2 0 1 1 3 1 1 2 2 1 1 3 54 
PB2 3 1 3 1 1 1 2 1 2 1 1 3 0 0 0 2 0 0 0 n/a 0 0 3 25 
Egg 3 3 1 2 2 1 1 2 1 2 1 1 n/a 1 1 1 1 1 2 2 1 0 0 30 
Total 6 4 4 3 3 2 3 3 3 3 2 3 0 1 1 3 1 1 2 2 1 1 3 55 
G04 4 
PB1 6 5 4 3 4 4 3 5 4 2 2 3 2 2 0 2 3 3 3 2 1 1 3 67 
PB2 3 2 1 5 4 2 2 2 4 3 3 2 4 1 0 2 3 4 1 0 0 0 2 50 
Egg 5 7 3 4 2 2 1 5 0 1 3 1 2 1 1 0 0 1 2 2 1 1 3 48 
Total 7 7 4 6 5 4 3 6 4 3 4 3 4 2 1 2 3 4 3 2 1 1 4 83 
G04 5 
PB1 5 6 5 4 4 5 5 3 4 4 3 4 2 2 3 5 3 2 3 2 1 1 4 80 
PB2 3 5 2 4 2 2 0 1 4 3 3 3 4 0 2 2 2 2 0 0 0 0 3 47 
Egg 2 3 3 n/a 2 5 5 4 0 1 0 1 2 2 3 3 1 2 3 2 1 1 3 49 
Total 5 7 5 4 4 6 5 4 4 4 3 4 4 2 4 5 3 3 3 2 1 1 5 88 
G06 1 
PB1 4 5 4 0 5 7 2 2 5 2 2 4 3 3 2 2 4 2 3 2 2 1 0 66 
PB2 4 5 3 0 3 3 1 3 4 2 0 2 2 0 0 1 3 2 0 1 1 1 n/a 41 
Egg 0 0 1 n/a 2 4 1 1 1 4 2 2 1 3 2 1 1 0 3 1 1 0 0 31 
Total 4 5 4 0 5 7 2 3 5 4 2 4 3 3 2 2 4 2 3 2 2 1 0 69 
G06 2 
PB1 6 6 5 5 4 5 3 4 4 5 3 3 4 0 3 3 3 2 2 2 1 2 6 81 
PB2 5 6 4 7 6 2 4 4 3 3 1 1 1 1 2 2 2 3 0 3 1 2 5 68 
Egg 3 4 5 2 6 3 5 2 1 2 2 2 3 1 1 1 1 3 2 1 0 0 1 51 
Total 7 8 7 7 8 5 6 5 4 5 3 3 4 1 3 3 3 4 2 3 1 2 6 100 
G06 3 
PB1 6 8 6 4 5 4 5 2 3 5 3 4 4 3 2 2 5 2 2 2 1 1 5 79 
PB2 5 4 6 4 2 2 4 1 0 5 0 4 1 3 2 0 3 3 1 0 0 0 1 50 
Egg 3 6 4 4 3 4 1 1 3 2 3 4 3 0 2 2 2 1 1 2 1 1 4 53 
Total 7 9 8 6 5 5 5 2 3 6 3 6 4 3 3 2 5 3 2 2 1 1 5 96 
G06 4 
PB1 5 6 3 2 4 4 3 3 2 2 3 3 3 1 3 3 2 2 0 2 1 2 2 59 
PB2 2 8 1 3 1 2 0 1 1 3 2 1 2 1 1 1 2 1 1 1 0 1 2 36 
Egg 3 4 2 3 3 2 3 2 3 3 1 2 3 2 2 2 0 1 1 3 1 1 0 47 
Total 5 9 3 4 4 4 3 3 3 4 3 3 4 2 3 3 2 2 1 3 1 2 2 73 
G07 2 
PB1 3 5 7 4 3 5 2 3 4 5 4 2 1 2 0 3 3 2 2 3 2 1 2 68 
PB2 1 3 3 2 2 2 2 2 2 1 3 1 1 0 n/a 0 2 2 0 2 1 1 2 33 
Egg 2 2 4 2 1 3 0 1 2 4 1 1 0 2 0 3 1 0 2 1 1 0 0 35 
Total 3 5 7 4 3 5 2 3 4 5 4 2 1 2 0 3 3 2 2 3 2 1 2 68 
G08 1 
PB1 3 3 4 0 2 2 2 2 2 3 2 3 1 2 1 3 1 2 2 2 1 1 2 46 
PB2 2 3 1 4 0 1 1 1 1 1 3 2 1 1 3 1 0 1 1 1 1 0 1 31 
Egg 1 2 3 4 2 1 3 1 1 4 1 1 0 1 2 2 1 3 1 1 0 1 1 37 
Total 3 4 4 4 2 2 3 2 2 4 3 3 1 2 3 3 1 3 2 2 1 1 2 57 
G08 2 
PB1 4 6 5 4 4 2 2 2 3 3 5 2 2 1 0 3 2 2 2 2 1 1 3 61 
PB2 1 3 2 1 3 3 3 1 2 2 2 1 0 1 n/a 0 3 0 0 1 0 1 4 34 
Egg 3 3 3 3 1 5 1 1 3 1 3 3 2 2 0 3 1 2 2 1 1 2 1 47 
Total 4 6 5 4 4 5 3 2 4 3 5 3 2 2 0 3 3 2 2 2 1 2 4 71 
G08 3 
PB1 5 2 7 4 6 4 2 2 5 3 3 4 4 2 3 3 3 2 2 2 2 1 2 73 
PB2 n/a 2 3 1 3 1 1 0 3 2 0 2 3 0 1 1 2 1 0 1 1 1 0 29 
Egg 5 2 4 3 3 3 1 2 2 1 3 2 1 2 2 2 1 1 2 1 1 0 2 46 
Total 5 3 7 4 6 4 2 2 5 3 3 4 4 2 3 3 3 2 2 2 2 1 2 74 
G09 1 
PB1 3 2 3 2 3 2 2 2 2 0 2 1 3 3 1 0 1 1 1 0 1 1 1 37 
PB2 2 2 3 2 3 1 0 1 1 1 2 0 2 1 2 n/a 1 0 1 1 1 1 0 28 
Egg 3 2 2 2 n/a 1 2 1 1 n/a 0 1 2 3 3 0 0 1 0 1 0 0 1 26 
Total 4 3 4 3 3 2 2 2 2 1 2 1 4 4 3 0 1 1 1 1 1 1 1 47 
G09 2 
PB1 3 4 2 2 5 3 3 2 4 2 3 3 1 1 1 1 2 2 1 3 0 1 2 51 
PB2 1 2 0 1 1 1 2 0 2 0 n/a 1 1 0 0 0 1 1 0 3 0 1 1 19 
Egg 2 2 2 1 4 2 1 2 2 2 3 2 0 1 1 1 1 1 1 0 n/a 0 1 32 
Total 3 4 2 2 5 3 3 2 4 2 3 3 1 1 1 1 2 2 1 3 0 1 2 51 
PSSC-
















  chromosome 
Total 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X 
LB03 2 
PB1 4 6 3 3 2 3 2 3 3 3 3 3 3 2 2 2 1 2 3 2 2 1 3 61 
PB2 2 5 1 3 3 1 3 2 3 2 2 2 1 1 2 1 1 1 1 1 1 0 2 41 
Embryo 2 3 2 4 3 2 3 1 0 3 3 1 2 1 0 1 0 3 2 1 1 1 3 42 
Total 4 7 3 5 4 3 4 3 3 4 4 3 3 2 2 2 1 3 3 2 2 1 4 72 
LB03 7 
PB1 5 2 3 3 3 3 2 2 2 2 3 2 2 1 1 2 3 2 2 3 1 1 2 52 
PB2 2 2 2 1 2 0 1 3 0 2 2 2 1 2 1 0 1 1 1 2 0 1 0 29 
Embryo 3 2 3 2 3 3 1 1 2 2 1 2 1 1 2 2 2 1 1 1 1 0 2 39 
Total 5 3 4 3 4 3 2 3 2 3 3 3 2 2 2 2 3 2 2 3 1 1 2 60 
LB03 8 
PB1 7 7 4 4 6 5 4 5 3 2 2 4 3 2 n/a 3 5 3 2 2 1 2 2 78 
PB2 4 3 2 4 3 2 2 1 0 3 1 4 1 0 n/a 1 2 2 1 0 0 1 3 40 
Embryo 3 4 2 2 3 3 2 4 3 3 1 2 2 2 3 2 3 1 1 2 1 1 3 53 
Total 7 7 4 5 6 5 4 5 3 4 2 5 3 2 3 3 5 3 2 2 1 2 4 87 
LB03 10 
PB1 4 4 4 5 2 5 2 4 5 2 3 3 2 2 1 0 4 2 0 2 2 1 6 65 
PB2 4 3 2 3 3 4 4 5 1 1 1 4 1 2 3 1 2 2 0 0 3 1 3 53 
Embryo 2 1 4 2 3 1 4 1 4 1 2 1 1 2 2 1 2 2 0 2 1 0 3 42 
Total 5 4 5 5 4 5 5 5 5 2 3 4 2 3 3 1 4 3 0 2 3 1 6 80 
LB03 11 
PB1 2 5 3 4 3 3 2 4 2 3 3 2 2 1 2 2 3 2 2 2 1 n/a 2 55 
PB2 2 3 1 1 4 2 2 4 1 3 1 2 2 2 1 0 2 2 1 1 1 1 1 40 
Embryo 2 2 4 3 1 1 2 0 1 2 2 2 0 3 1 2 1 0 1 1 2 1 1 35 
Total 3 5 4 4 4 3 3 4 2 4 3 3 2 3 2 2 3 2 2 2 2 1 2 65 
LB03 12 
PB1 9 10 6 6 9 5 5 7 5 5 5 6 1 2 3 4 3 3 2 3 2 1 3 105 
PB2 5 6 5 3 4 2 2 3 4 4 3 6 1 4 2 1 2 1 3 3 0 0 3 67 
Embryo 4 4 5 5 5 3 7 4 7 3 2 4 0 2 3 3 1 4 1 0 2 1 2 72 
Total 9 10 8 7 9 5 7 7 8 6 5 8 1 4 4 4 3 4 3 3 2 1 4 122 
LB03 13 
PB1 3 3 2 2 2 3 3 2 2 2 2 2 3 1 1 2 2 2 2 2 0 0 2 45 
PB2 3 2 2 1 1 1 2 1 1 0 0 2 2 3 2 1 1 2 0 0 0 0 3 30 
Embryo 2 3 0 1 3 2 1 1 3 2 2 0 1 2 1 1 1 2 2 2 0 0 1 33 
Total 4 4 2 2 3 3 3 2 3 2 2 2 3 3 2 2 2 3 2 2 0 0 3 54 
LB03 14 
PB1 5 3 3 4 5 5 5 2 2 3 2 3 3 3 1 4 1 3 0 2 1 0 3 63 
PB2 1 4 3 1 2 4 4 1 3 1 3 2 0 0 0 3 2 1 0 2 0 0 4 41 
Embryo 4 5 2 3 3 1 3 1 1 2 3 3 3 3 1 3 1 2 0 0 1 0 1 46 
Total 5 6 4 4 5 5 6 2 3 3 4 4 3 3 1 5 2 3 0 2 1 0 4 75 
LB03 16 
PB1 7 2 5 2 4 3 5 4 3 2 3 2 2 3 3 3 2 2 2 2 0 1 2 64 
PB2 6 2 2 2 2 3 2 3 2 1 1 2 1 1 0 2 2 0 2 0 0 1 2 39 
Embryo 3 2 3 0 2 2 3 1 1 1 2 2 1 2 3 1 2 2 0 2 0 0 0 35 
Total 8 3 5 2 4 4 5 4 3 2 3 3 2 3 3 3 3 2 2 2 0 1 2 69 
PSSC-
aneuploid MI NDJ MII NDJ RS-aneuploid RS-euploid 
PSSC-
Euploid 
 
 
 
